News & Updates
Filter by Specialty:
Men with untreated hypogonadism at risk of long-term morbidity, death
Untreated hypogonadism in men appears to elevate the risk of morbidity in the long term and early mortality based on time-related measures of risk only, according to a study.
Men with untreated hypogonadism at risk of long-term morbidity, death
31 Jul 2022
Thyroid hormone sensitivity tied to advanced liver fibrosis in NAFLD
In euthyroid patients with nonalcoholic fatty liver disease (NAFLD), higher values of thyroid hormone sensitivity markers, such as the thyroid-stimulating hormone (TSH) index (TSHI) and thyroid feedback quantile-based index (TFQI), appear to aggravate the risk of advanced fibrosis, a recent study has found.
Thyroid hormone sensitivity tied to advanced liver fibrosis in NAFLD
30 Jul 2022
Low free sugar diet improves clinical biomarkers in NAFLD patients
In overweight/obese patients with nonalcoholic fatty liver disease (NAFLD), a low free sugar diet may result in decreased hepatic steatosis and fibrosis, as well as better glycaemic indices and lower concentrations of biomarkers of inflammation, triglycerides (TG), and total cholesterol (TC) levels, suggests a recent study.
Low free sugar diet improves clinical biomarkers in NAFLD patients
30 Jul 2022
Is pre-emptive pharmacogenetic testing in CRC patients viable within a community oncology clinic?
A recent study has shown that it is possible to implement pre-emptive pharmacogenetic testing into a community-based oncology clinic with results interpretation available for colorectal cancer patients before their scheduled initiation of chemotherapy.
